Merck\'s Keytruda wins FDA approval to treat head and neck cancer

Merck's Keytruda wins FDA approval to treat head and neck cancer

The drug was approved for use as a monotherapy, as well as in combination with a common chemotherapy regimen.Reuters  |  June 11, 2019, 16:42 IST
Merck's Keytruda wins FDA approval to treat head and neck cancer Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S . Food and Drug Administration to treat a type of head and neck cancer.

The drug was approved for use as a monotherapy, as well as in combination with a common chemotherapy regimen, to treat previously untreated patients with head and neck squamous cell carcinoma, Merck said.